Latest news with #P.C.
Business Upturn
8 hours ago
- Business
- Business Upturn
MONGODB ALERT: Bragar Eagel & Squire, P.C. is Investigating MongoDB, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In MongoDB (MDB) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in MongoDB between August 31, 2023 and May 30, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. MongoDB between August 31, 2023 and May 30, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against MongoDB, Inc. (NASDAQ:MDB) on behalf of long-term stockholders following a class action complaint that was filed against MongoDB on July 9, 2024 with a Class Period from August 31, 2023 and May 30, 2024. Our investigation concerns whether the board of directors of MongoDB have breached their fiduciary duties to the company. Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against MongoDB, Inc. (NASDAQ: MDB) on behalf of long-term stockholders following a class action complaint that was filed against MongoDB on July 9, 2024 with a Class Period from August 31, 2023 to May 30, 2024. Our investigation concerns whether the board of directors of MongoDB have breached their fiduciary duties to the company. According to the complaint, on March 7, 2024, MongoDB reported strong Q4 2024 results and then announced lower than expected full-year guidance for 2025. MongoDB attributed it to the Company's change in its 'sales incentive structure' which led to a decrease in revenue related to 'unused commitments and multi-year licensing deals.' Following this news, MongoDB's stock price fell by $28.59 per share to close at $383.42 per share. Later, on May 30, 2024, MongoDB further lowered its guidance for the full year 2025 attributing it to 'macro impacting consumption growth.' Analysts commenting on the reduced guidance questioned if changes made to the Company's marketing strategy 'led to change in customer behavior and usage patterns.' Following this news, MongoDB's stock price fell by $73.94 per share to close at $236.06 per share. If you are a long-term stockholder of MongoDB, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Business Upturn
17-07-2025
- Business
- Business Upturn
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Urges Investors in PepGen, Inc. (PEPG) to Inquire About Their Rights in Class Action Lawsuit
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PepGen (PEPG) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in PepGen between March 7, 2024 and March 3, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against PepGen, Inc. ('PepGen' or the 'Company') (NASDAQ: PEPG) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired PepGen securities between March 7, 2024 and March 3, 2025, both dates inclusive (the 'Class Period'). Investors have until August 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was dangerous or otherwise deficient for purposes of U.S. Food and Drug Administration ('FDA') approval; (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51's clinical, regulatory, and commercial prospects were overstated; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. If you purchased or otherwise acquired PepGen shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Business Upturn
16-07-2025
- Business
- Business Upturn
ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Organon & Co. (OGN) to Inquire About Their Rights in Class Action Lawsuit
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Organon (OGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between November 3, 2022 and April 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organon & Co. ('Organon' or the 'Company') (NYSE:OGN) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Organon securities between November 3, 2022 and April 30, 2025, both dates inclusive (the 'Class Period'). Investors have until July 22, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Organon's priorities, particularly, related to capital allocation through quarterly dividends. Notably, defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Following this news, the price of Organon's common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon's stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day. If you purchased or otherwise acquired Organon shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Passmore, Esq.(212) 355-4648 [email protected]
Business Upturn
12-07-2025
- Business
- Business Upturn
STRATEGY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Strategy Incorporated and Urgently Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Strategy (MSTR) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Strategy between April 30, 2024 and April 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Strategy Incorporated ('Strategy' or the 'Company') (NASDAQ:MSTR) in the United States District Court for the Eastern District of Virginia on behalf of all persons and entities who purchased or otherwise acquired Strategy securities between April 30, 2024 and April 4, 2025, both dates inclusive (the 'Class Period'). Investors have until July 15, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding Strategy's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) the anticipated profitability of the Company's bitcoin-focused investment strategy and treasury operations was overstated; (2) the various risks associated with bitcoin's volatility and the magnitude of losses Strategy could recognize on the value of its digital assets following its adoption of ASU 2023-08 were understated; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times. If you purchased or otherwise acquired Strategy shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected]
Yahoo
01-07-2025
- Business
- Yahoo
This Little-Known Estate Planning Strategy Can Help Family Members Care For You
If you can't fully care for yourself anymore, you might rely on loved ones to help out. You're certainly not alone in this situation. Nearly two-thirds — 63% — of informal caregivers are family members, but only 9% are paid, according to the One America 2024 Caregiver Study. No doubt, you're grateful for your loved ones' help and want to compensate them for their time. Keep reading to find out how to use an estate planning strategy to pay them back in a manner that works for everyone. Trending Now: For You: 'A caregiving agreement between parent(s) and an adult child or grandchild is something we elder law attorneys do regularly,' said Evan Farr, certified elder law attorney (CELA), certified analytics professional (CAP) and principal attorney at Farr Law Firm, P.C. 'It requires entering into a written contract clearly spelling out the terms of the care.' In most states, he said a geriatric care manager should be involved with the creation of this agreement, to help ensure that Medicaid doesn't consider these Payments gifts in the future. This can also help avoid family fights caused by siblings believing the caregiver is overpaid. Check Out: 'This type of agreement is often used as a way to engage in 'smart spend down' of assets for the elder, who is eventually hoping to qualify financially for Medicaid,' he said. 'In this scenario, the parent of course pays the child on a regular basis for the child's care.' In this situation, the parent is technically supposed to register as an employer and treat the child as an employee — including issuing a W-2 and paying payroll taxes, he said. This might sound intimidating, be he noted there are several online companies that can handle this for you. 'Of course not everyone cares about being tax-compliant and many people deal with the money themselves and don't worry about taxes,' he added. If the parent doesn't currently have the money to pay the child and the child is okay with that, they can enter into an agreement for future payment, Farr said. This would typically occur upon the sale of the parent's home. In this case, the parent and child would agree to a type of loan called a delayed payment agreement, he said. This can either carry interest or not, depending on the terms of the loan. 'This delayed payment agreement is similar to a revolving line of credit promissory note, where the caregiver keeps track of their hours and eventually gets paid the total amount of their hours — plus any interest — when the house is sold,' he said. In a revocable living trust with caregiver compensation provisions, the parent changes their living trust to direct caregivers to be paid out of income from their investment accounts or other trust assets, said Seann Malloy, founder and managing partner at Malloy Law Offices, LLC. This prevents the parent from having to make payments from their checking account. 'This approach is well-suited to elderly individuals who are informally cared for by family members — where the family caregivers experience reduced work or out-of-pocket costs of care,' Malloy said, who practices civil litigation, with a focus on estate planning. 'It is a way of guaranteeing that compensation is fair and at the same time maintaining family unity and transparency.' He said one of the main advantages to this approach is that it doesn't involve cashing in investment accounts or selling property. However, he noted that it does have potential drawbacks, including the need for the agreement to be properly worded to avoid IRS scrutiny. More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 Warren Buffett: 10 Things Poor People Waste Money On 9 Downsizing Tips for the Middle Class To Save on Monthly Expenses This article originally appeared on This Little-Known Estate Planning Strategy Can Help Family Members Care For You
